SMTL ID : 8etr.1

CryoEM Structure of NLRP3 NACHT domain in complex with G2394

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: T.100, M.390 Ligands: ADP.2 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:T.100

1 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)

ADP.2: 19 residues within 4Å: Chain A: R.34, Y.35, T.36, L.38, A.95, G.96, I.97, G.98, K.99, T.100, I.101, F.240, Y.248, P.279, L.280, W.283, H.389, M.390 Ligands: MG.1 12 PLIP interactions: 12 interactions with chain A Hydrogen bonds: A:T.36, A:T.36, A:G.96, A:I.97, A:G.98, A:K.99, A:T.100, A:T.100, A:I.101 Salt bridges: A:K.99, A:H.389, A:H.389

1 x WTN: (6S,8R)-N-[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl]-6-(methylamino)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide(Non-covalent)

WTN.3: 18 residues within 4Å: Chain A: A.94, A.95, R.218, P.219, M.275, F.277, I.278, L.280, V.281, T.306, Y.310, T.391, F.442, R.445, L.495, E.496, Y.499, M.528 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.278, A:L.280, A:T.306, A:Y.499 Hydrogen bonds: A:A.95, A:A.95, A:R.445, A:R.445

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

McBride, C. et al., Overcoming Preclinical Safety Obstacles to Discover ( S )- N -((1,2,3,5,6,7-Hexahydro- s -indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5 H -pyrazolo[5,1- b ][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 Inhibitor. J.Med.Chem. (2022)

Release Date

2022-11-02

Peptides

NACHT, LRR and PYD domains-containing protein 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

NACHT, LRR and PYD domains-containing protein 3